Literature DB >> 11376937

Genetic rationale for microheterogeneity of human diphosphoinositol polyphosphate phosphohydrolase type 2.

J J Caffrey1, S B Shears.   

Abstract

Selective expression of enzymes that adjust the intensity of turnover of diphosphoinositolpolyphosphates may regulate vesicle trafficking and DNA repair. For example, the type 2 human diphosphoinositolpolyphosphate phosphohydrolases (hDIPP2alpha and 2beta) are distinguished by a solitary amino-acid residue; the type 2beta isoform contains Gln86 whereas the type 2alpha isoform does not, yet the latter has 2-5 fold more catalytic activity than its beta counterpart (J. Biol.Chem. (2000) 12730). We discovered that both alpha and beta-type mRNAs were co-expressed in clonal cell-lines. We sought a genetic explanation for this microheterogeneity. Two BACs containing distinct, but intronless, hDIPP2beta genes were cloned. Only one of these genes could potentially give rise to our previously characterized hDIPP2beta mRNA; the other gene has several sequence differences and, in any case, is likely a processed pseudogene. These BACS were mapped to 1q12-q21 and 1p12-p13 by FISH. No analogous intronless hDIPP2alpha gene was detected by analysis of 21 individual genomic DNAs. However, sequence analysis of a third hDIPP2 gene (at 12q21) places the Gln86 CAG codon within an AGCAG pentamer, offering adjacent, alternate intronic 3'-boundaries. Thus, 'intron boundary skidding' by spliceosomes provides a mechanism for yielding both hDIPP2alpha and hDIPP2beta mRNAs. Our studies expand the repertoire of molecular mechanisms regulating diphosphoinositolpolyphosphate metabolism and function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376937     DOI: 10.1016/s0378-1119(01)00446-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

Review 1.  The inositol pyrophosphate pathway in health and diseases.

Authors:  Anutosh Chakraborty
Journal:  Biol Rev Camb Philos Soc       Date:  2017-12-27

Review 2.  Inositol pyrophosphates: structure, enzymology and function.

Authors:  Christopher John Barker; Christopher Illies; Gian Carlo Gaboardi; Per-Olof Berggren
Journal:  Cell Mol Life Sci       Date:  2009-08-28       Impact factor: 9.261

Review 3.  Diphosphoinositol polyphosphates: metabolic messengers?

Authors:  Stephen B Shears
Journal:  Mol Pharmacol       Date:  2009-05-13       Impact factor: 4.436

Review 4.  The enzymes of human diphosphoinositol polyphosphate metabolism.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  FEBS J       Date:  2013-11-05       Impact factor: 5.542

5.  Genome-wide profiling of the PIWI-interacting RNA-mRNA regulatory networks in epithelial ovarian cancers.

Authors:  Garima Singh; Jyoti Roy; Pratiti Rout; Bibekanand Mallick
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.